Skip to main content
. 2017 Dec 18;9(2):2208–2219. doi: 10.18632/oncotarget.23367

Table 1. Characteristics of the included studies.

Author Year Country N (F/M) Mean age Study Disease Follow-up time Measure methods Cut-off value Estimate Adjusted HR/OR
Prospective studies
Tzoulaki 2007 UK 1592 (783/809) 64.9 The Edinburgh Artery Study Stroke mean 17 yrs ELISA tertile HR Yes
Wannamethee 2012 UK 3358 (0/3358) 68.4 The British Regional Heart Study Stroke mean 9 yrs ELISA tertile/per SD HR Yes
Zakai 2017 USA 1750 (—/—) The REGARDS Study Stroke median 5.8 yrs ITA quintile HR Yes
Di Castelnuovo 2014 Italy 832 (550/282) The EPICOR Study Stroke/HS/IS mean 9 yrs ITA quartile/per SD HR Yes
Folsom 2016 USA 11415 (6632/4783) 59.8 The ARIC Study Stroke/HS/IS median 18 yrs ITA quintile/per SD HR Yes
Smith 2005 UK 2208 (0/2208) 56.9 The Caerphilly Study IS median 13 yrs ELISA tertile HR Yes
Zakai-2 2017 USA 1052 (530/522) 65.1 The REGARDS Study HS median 5.8 yrs ITA tertile/per SD HR Yes
Case-control studies
Anzej 2007 Slovenia 90 (55/35) 38.5 AIS ITA OR NR
Kaplan 2008 USA 1944 (1944/0) The WHI observational study AIS ITA OR Yes
Shi 2014 China 214 (90/124) 67.4 AIS ITA quartile OR Yes

N (F/M): number of patients (Female/Male), The REGARDS Study: The REasons for Geographic and Racial Differences in Stroke Study, The EPICOR Study: The European Prospective Investigation into Cancer and Nutrition-Italy Cohort Study, The ARIC Study: The Atherosclerosis Risk in Communities Study, The WHI observational study: The Women's Health Initiative observational study, HS: hemorrhagic stroke, IS: ischemic stroke, AIS: acute ischemic stroke, yrs: years, ELISA: enzyme-linked immunosorbent assay, ITA: immunoturbidimetric assay, SD: standard deviation, HR: hazard ratio, OR: odds ratio, NR: not reported.